Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07694063

Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine

Conditions: Migraine

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: University of Seville

Location: University Hospital Virgen del Rocio Seville Sevilla

Summary

This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.

Eligibility Criteria

Inclusion Criteria * Adults aged 18-65 years * Diagnosis of episodic high-frequency migraine according to ICHD criteria * Diagnosis confirmed by a neurologist * At least 1-year history of migraine * Receiving stable pharmacological treatment for ≥3 months before enrollment * Willing to maintain stable medication during the study * Ability to understand study procedures and complete assessments * Signed informed consent * Willingness to be randomized Exclusion Criteria * Other significant neurological disorders * Severe psychiatric conditions affecting participation * Medical contraindications to moderate physical activity * Chronic migraine (≥15 headache days/month) * Use of more than one preventive migraine medication * Lack of Spanish language comprehension * Lack of internet access or digital skills for online intervention

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07694063). StuddyBuddy aggregates publicly available trial information.